We are committed to the safety and well-being of our clients, their families, our staff and the community.
We’ve implemented changes across all of our programs as we respond to the COVID-19 pandemic and work to mitigate the risk of virus transmission, while providing premier mental health treatment to those living with mental health challenges.
We are open and admitting new clients to our Residential, Partial Hospitalization, and Evening Intensive Outpatient Programs and have compiled a list of program and process changes to help you navigate and better understand our current operations. We are continuing Virtual Day IOP and outpatient services at this time.
We continue to monitor information from the CDC, state and federal authorities and will implement updates as recommendations change.
STAFF & CAMPUS UPDATES
- We are disinfecting surfaces throughout our campus regularly, with an intensified focus for high touch/contact areas based on frequency of use.
- Meeting spaces, group size and common areas have been altered to allow for proper social distancing per guidelines.
- Staff and team members, including essential vendors, are screened daily before entering the building, including temperature checks.
- Staff members are required to wear personal protective equipment appropriate for specific client care and other job responsibilities.
- Staff members who become symptomatic must not report for work and notify their supervisor.
- If a staff member has a person in their household test positive for COVID-19, they must stay home and self-quarantine for 14 days.
- Visitors are not allowed on campus.
- Staff members who are not essential to the delivery of treatment and are able to perform their job functions remotely are doing so to lessen the number of individuals on campus.
- Furniture and common areas have been altered to allow for social distancing. All client bedrooms are private, single rooms.
- Clients will be required to wear face masks to mitigate the spread of the virus unless they are eating or alone in their rooms.
- Each client’s health is monitored daily, including multiple temperature checks, other signs and symptom screens.
- Off-campus outings and family visits have been suspended.
- If a residential client exhibits symptoms of COVID-19, they will be isolated in their room and be referred for testing. If the test returns positive, the client will be medically discharged to self-isolate at home for 14 days. Upon discharge, they will be directed to contact their healthcare provider. The client will be notified of their test result. Discharged clients are eligible for re-admission after the required 14-day quarantine at home.
- Our Day Intensive Outpatient Program will continue to operate virtually.
- HopeWay Psychiatry & Associates will continue to offer telemedicine appointments virtually.
CHANGES FOR NEW ADMISSIONS
- All prospective clients will be screened by phone and/or videoconferencing before starting the admissions process.
- All biopsychosocial assessments will be performed by phone or virtually.
- Newly admitted clients may be accompanied to HopeWay by one guest, and that one support person will be allowed in the main lobby and the designated office where the consult occurs and required to wear a face mask.
- In the event the client or anyone accompanying the client answers “yes” to any screening question and/or has a temperature of 99.6 F degrees or higher, our medical team will be consulted regarding the start of the onsite admissions psychiatric consultation.
We encourage you to follow the CDC guidelines on how to protect yourself and others from COVID-19. Please continue to wash your hands for 20 seconds, use hand sanitizer when washing is not an option, put a 6-foot distance between yourself and others, cover your mouth and nose with a cloth face cover when around others, and clean and disinfect frequently touched surfaces daily in your home. We thank you for your continued commitment to the mitigation of COVID-19 and we look forward to serving those struggling with mental health diagnoses, medical co-morbities and/or substance use disorders.